1. High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19.
- Author
-
De Zuani M, Lazničková P, Tomašková V, Dvončová M, Forte G, Stokin GB, Šrámek V, Helán M, and Frič J
- Subjects
- Aged, CD4-CD8 Ratio methods, Female, Humans, Immunophenotyping methods, Intensive Care Units, Lymphocyte Count methods, Male, Middle Aged, Prospective Studies, SARS-CoV-2 immunology, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, COVID-19 immunology
- Abstract
Around half of people with severe COVID-19 requiring intensive care unit (ICU) treatment will survive, but it is unclear how the immune response to SARS-CoV-2 differs between ICU patients that recover and those that do not. We conducted whole-blood immunophenotyping of COVID-19 patients upon admission to ICU and during their treatment and uncovered marked differences in their circulating immune cell subsets. At admission, patients who later succumbed to COVID-19 had significantly lower frequencies of all memory CD8+ T cell subsets, resulting in increased CD4-to-CD8 T cell and neutrophil-to-CD8 T cell ratios. ROC and Kaplan-Meier analyses demonstrated that both CD4-to-CD8 and neutrophil-to-CD8 ratios at admission were strong predictors of in-ICU mortality. Therefore, we propose the use of the CD4-to-CD8 T cell ratio as a marker for the early identification of those individuals likely to require enhanced monitoring and/or pro-active intervention in ICU., (© 2021 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology.)
- Published
- 2022
- Full Text
- View/download PDF